Inventor · disambiguated record
Aleksander S. Popel
Also filed as: POPEL ALEKSANDER S
14 granted patents·5 pending applications·98 citations·filing 2006–2020
91Inventor score
Top patents by PatentIndex Score
19 records- 0193US8507434B2Peptide modulators of angiogenesis and use thereofPOPEL ALEKSANDER S·Filed 2008·Granted Aug 13, 2013·39 cites·9 claims
- 0292US8557772B2Compositions having antiangiogenic activity and uses thereofPOPEL ALEKSANDER S·Filed 2012·Granted Oct 15, 2013·37 cites·12 claims
- 0384US11981754B2Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseasesUNIV JOHNS HOPKINS·Filed 2020·Granted May 14, 2024·1 cites·29 claims
- 0483US9056923B2Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphagiogenesis-dependent diseasesPOPEL ALEKSANDER S·Filed 2011·Granted Jun 16, 2015·3 cites·5 claims
- 0580US10774112B2Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseasesUNIV JOHNS HOPKINS·Filed 2017·Granted Sep 15, 2020·1 cites·21 claims
- 0678US9802984B2Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseasesUNIV JOHNS HOPKINS·Filed 2014·Granted Oct 31, 2017·3 cites·51 claims
- 0777US10786463B2Peptide/particle delivery systemsUNIV JOHNS HOPKINS·Filed 2017·Granted Sep 29, 2020·1 cites·6 claims
- 0877US9717694B2Peptide/particle delivery systemsGREEN JORDAN JAMIESON·Filed 2011·Granted Aug 1, 2017·8 cites·2 claims
- 0976US10106597B2Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseasesUNIV JOHNS HOPKINS·Filed 2016·Granted Oct 23, 2018·1 cites·17 claims
- 1076US9187544B2Peptide modulators of angiogenesis and use thereofUNIV JOHNS HOPKINS·Filed 2013·Granted Nov 17, 2015·2 cites·7 claims
- 1174US9187539B2Compositions having antiangiogenic activity and uses thereofUNIV JOHNS HOPKINS·Filed 2013·Granted Nov 17, 2015·2 cites·8 claims
- 1272US11155603B2Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis- dependent diseasesUNIV JOHNS HOPKINS·Filed 2020·Granted Oct 26, 2021·0 cites·11 claims
- 1366US10774131B2Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseasesUNIV JOHNS HOPKINS·Filed 2018·Granted Sep 15, 2020·0 cites·18 claims
- 1456US2015307592A1Mimetic peptides derived from collagen type iv and their use for treating angiogenesis- and lymphangiogenesis- dependent diseasesUNIV JOHNS HOPKINS·Filed 2015·Application pending·0 cites
- 1553US2010144641A1Compositions Having Antiangiogenic Activity and Uses ThereofPOPEL ALEKSANDER S·Filed 2006·Application pending·0 cites
- 1645US2020179285A1Biodegradable microparticles for sustained delivery of anti-angiogenic peptideUNIV JOHNS HOPKINS·Filed 2018·Application pending·0 cites
- 1740US11674959B2Methods for identifying and preparing pharmaceutical agents for activating Tie1 and/or Tie2 receptorsUNIV JOHNS HOPKINS·Filed 2018·Granted Jun 13, 2023·0 cites·15 claims
- 1839US2019225670A1Compounds and methods for activating tie2 signalingASCLEPIX THERAPEUTICS LLC·Filed 2017·Application pending·0 cites
- 1938US2018339024A1Peptides with anti-angiogenic, anti-lymphangiogenic, and anti-edemic properties and nanoparticle formulationsASCLEPIX THERAPEUTICS LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aleksander S. Popel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →